Activated peripheral blood mononuclear cells detected in lupus patients using cDNA coding for proliferating cell nuclear antigen

References

• Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228–34.
   Google Scholar
• Takasaki Y, Fishwild D, Tan EM. Characterization of proliferating 21. cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984;159: 981–92.
   Google Scholar
• Ogata K, Ogata Y, Nakamura RM, Tan EM. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen 22. (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. J Immunol 1985;135:2623–7.
   Google Scholar
• Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. Its distribution in 23. synchronized cells. J Exp Med 1985;154: 1899–909.
   Google Scholar
• Matsumoto K, Moriuchi T, Koji T, Nakane PK. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA)/ 24. cyclin. EMBO J 1987;6:637–42.
   PubMed Web of Science ®Google Scholar
• Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-d. Nature 25. 1987;326:515–7.
   Google Scholar
• Prelich G, Kostura M, Marshak DR, Mathews MB, Stillman B. The 26. cell-cycle-regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 1987;326: 471–5.
   Google Scholar
• Takasaki Y, Kogure T, Takeuchi K, Kaneda K, Yano T, Hirokawa 27. K, et al. Reactivity of antiproliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001;166:4780-7.28.
   Google Scholar
• Shivji MK, Podust VN, Hubscher U, Wood RD. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the 29. presence of PCNA, RFC, and RPA. Biochemistry 1995;34:5011–7.
   Google Scholar
• Chuang LSH, Ian HI, Koh TW, Ng HH, Xu G, Li BFL. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target 30. for p21WAF1. Science 1997;277: 1996–2000.
   Google Scholar
• Shibahara K, Stillman B. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Cell 1999;96:575-85.31.
   Google Scholar
• Chen IT, Smith ML, O'Connor PM, Fornace Jr AJ. Direct interac-tion of Gadd45 with PCNA and evidence for competitive interac-tion of Gadd45 and p21Wafl/Cipl with PCNA. Oncogene 1995;10: 1931–7.32.
   Google Scholar
• Hannan RD, Cavanaugh A, Hempel WM, Moss T, Rothblum L. Identification of a mammalian RNA polymerase I holoenzyme containing components of the DNA repair/replication system. Nucleic Acid Res 1999;27:3720-7.33.
   Google Scholar
• Takasaki Y, Robinson WA, Tan EM. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia. J Natl Cancer Inst 1984;73:655–61.
   Google Scholar
• Ito M, Tsurusawa M, Zha Z, Kawai S, Takasaki Y, Fujimoto T. 34. Cell proliferation in childhood leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis. Cancer 1992;69: 2176–82.35.
   Google Scholar
• Takasaki Y, Ohgaki M, Kodama A, Ogata K, Hashimoto H, Shirai T, et al. A sandwich-type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA/cyclin) using monoclonal antibodies. J Immunol Methods 1990;132:227–37.
   PubMed Web of Science ®Google Scholar
• Haneda H, Katabami M, Miyamoto H, Isobe H, Shimizu T, 36. Ishiguro A, et al. The relationship of the proliferating cell nuclear antigen protein to cis-diammine-dichloroplatinum(II) resistance of a murine leukemia cell line P338/CDDP. Oncology 1991;48: 744–8.
   Google Scholar
• Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, 37. Takasaki Y, et al. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: compari- 38. son with histopathological parameters. Modern Pathol 1994;7: 37–43.
   Google Scholar
• Tokuda Y, Saiga T, Mukai K, Takasaki Y. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell 39. nuclear antigen in junctional and compound nevi than intradermal nevi. J Am Acad Dermatol 1994;31:220–4.
   Google Scholar
• Kawasaki H, Mukai K, Yajima S, Tanaka R, Takayama J, Takasaki Y, et al. Prognostic value of proliferating cell nuclear antigen 40. (PCNA) imunostaining in neuroblastoma. Med Pediatr Oncol 1995;24:300–4.
   PubMedGoogle Scholar
• Takahashi T, Takasaki Y, Yano T, Takeuchi K, Oshimi K, Hashimoto H. Detection of proliferating cell nuclear antigen (PCNA) in peripheral blood mononuclear cells and sera of patients with malignant lymphoma. Leuk Lymphoma 1997;28:113–25.
   PubMed Web of Science ®Google Scholar
• Murashima A, Takasaki Y, Ohgaki M, Ohgaki M, Hashimoto H, Hirose S. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 1990;10:28–37.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JE, Jasi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241–8.
   PubMed Web of Science ®Google Scholar
• BOyum A. Separation of leukocytes from blood and bone marrow. Scand J Chin Lab Invest 1968;21:97–105.
   Google Scholar
• Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294–9.
   PubMed Web of Science ®Google Scholar
• Fu SM, Chiorazzi N, Wang CY, Montrazeri G, Kunkel HG, Ko HS, et al. Ia-bearing T lymphocytes in man: their identification and role in the generation of allogenic helper activity. J Exp Med 1978;148:1423–8.
   PubMed Web of Science ®Google Scholar
• Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG. Peripheral blood Ia-positive T cells. J Exp Med 1980;151:91–100.
   PubMed Web of Science ®Google Scholar
• Hishikawa T, Tokano Y, Sekigawa I, Ando S, Takasaki Y, Hashimoto H, et al. HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990;55:285–96.
   PubMedGoogle Scholar
• Uchiyama T, Broder S, Waldman TA. A monoclonal antibody (anti-Tac) reactive with activated and functional mature human T cells. I. Production of anti-Tac monoclonal antibody and distribu-tion of Tac cells. J Immunol 1981;126:1393–7.
   Google Scholar
• Wigfall DR, Sakai RS, Wallace DJ, Jordan SC. Interleukin-2 receptor expression in peripheral blood lymphocytes from sys-temic lupus erythematosus patients: relationship to clinical activity. Chin Immunol Immunopathol 1988;47:354–62.
   PubMedGoogle Scholar
• Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okumura K, Hirose S. Relation between soluble interleukin-2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989;48:803–9.
   PubMedGoogle Scholar
• Szepesi A, Gelfand EW, Lucas JJ. Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in nor-mal and transformed human T lymphocytes. Blood 1994;84:3413–
   Google Scholar
• Moore KS, Sullivan K, Tan EM, Prystowsky MB. Proliferating cell nuclear antigen/cyclin is an interleukin-2 responsive gene. J Biol Chem 1987;262:8447–50.
   PubMedGoogle Scholar
• Boumpas DT, Tsokos GC, Mann DL, Eleftheriades EG, Harris CC, Mark GE. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythemato-sus and other autoimmune diseases. Arthritis Rheum 1986;29:755–60.
   PubMed Web of Science ®Google Scholar
• Shipman-Appasamy P, Cohen KS, Prystowky MB. Interleukin-2-induced expression of proliferating cell nuclear antigen is regulated by transcriptional and post-transcriptional mechanisms. J Biol Chem 1990;265: 19180–4.
   Google Scholar
• Huang Y-P, Perrin LH, Miescher PA, Zubler RH. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 1988;141: 827–33.
   Google Scholar
• Jaskulski D, Gatti G, Travalli S, Calabretta B, Baserga R. Regula-tion of the proliferating cell nuclear antigen cyclin and thymidine kinase mFtNA levels by growth factors. J Biol Chem 1988;263: 10175–9.
   Google Scholar
• Bravo R, MacDonald-Bravo H. Induction of the nuclear protein "yclin" in quiescent mouse 3T3 cells stimulated by serum and growth factor. Correlation with DNA synthesis. EMBO J 1984;3:3177–81.
   Google Scholar
• Chang CD, Ottavio L, Travail S, Lipson KE, Baserga R. Transcrip-tional and posttranscriptional regulation of the proliferating cell nuclear antigen gene. Mol Cell Biol 1990;10:3289–96.
   Google Scholar